Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP27X divergent transcript (USP27X-AS1) is a long non-coding RNA gene located on the X chromosome (chrX: 49876724) that is transcribed antisense to the USP27X locus[2]. There is insufficient published evidence that it produces a protein or serves as a direct therapeutic target; rather, it may regulate its neighboring USP27X gene (an enzyme involved in deubiquitination) via antisense mechanisms. No drugs or diseases are currently linked to direct targeting or biomarker roles for USP27X-DT/USP27X-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on USP27X divergent transcript (USP27X-AS1).